Concomitant Endometrioid Endometrial Carcinoma and Adult-Type Granulosa Cell Tumor in an Elderly Patient with Mismatch Repair Deficiency: A Case Report

Öz

We present the case of an 82-year-old woman who was admitted with postmenopausal bleeding and was subsequently diagnosed with synchronous endometrioid endometrial carcinoma (FIGO grade 2) and adult-type granulosa cell tumor of the ovary. Histopathological and immunohistochemical analyses revealed mismatch repair (MMR) deficiency with loss of MLH1 and PMS2 expression. The coexistence of these two tumor types in a single patient, particularly in the context of MMR deficiency, is extremely rare. The case is discussed in light of current literature with consideration of its relevance to Lynch syndrome and the implications for genetic counseling.

Anahtar Kelimeler

• Endometrial carcinoma
• Granulosa cell tumor
• MMR deficiency
• Lynch syndrome
• Synchronous tumors
• Postmenopausal bleeding

Mismatch Repair Yetmezliği Olan Yaşlı Bir Hastada Eş Zamanlı Endometrioid Endometriyal Karsinom ve Erişkin Tip Granüloza Hücreli Tümör: Bir Olgu Sunumu

Öz

We present the case of an 82-year-old woman who was admitted with postmenopausal bleeding and was subsequently diagnosed with synchronous endometrioid endometrial carcinoma (FIGO grade 2) and adult-type granulosa cell tumor of the ovary. Histopathological and immunohistochemical analyses revealed mismatch repair (MMR) deficiency with loss of MLH1 and PMS2 expression. The coexistence of these two tumor types in a single patient, particularly in the context of MMR deficiency, is extremely rare. The case is discussed in light of current literature with consideration of its relevance to Lynch syndrome and the implications for genetic counseling.

Anahtar Kelimeler

• Endometriyal karsinom
• Granüloza hücreli tümör
• MMR yetmezliği
• Lynch sendromu
• Senkron tümörler
• Postmenopozal kanama

Kaynakça

1. 1. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17-48.
2. 2. Galant N, Krawczyk P, Monist M, Obara A, Gajek Ł, Grenda A, et al. Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection. Int J Mol Sci. 2024;25(11).
3. 3. Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol. 2003;21(6):1180-9.
4. 4. Jamieson S, Fuller PJ. Molecular pathogenesis of granulosa cell tumors of the ovary. Endocr Rev. 2012;33(1):109-44.
5. 5. Murali R, Soslow RA, Weigelt B. Classification of endometrial carcinoma: more than two types. Lancet Oncol. 2014;15(7):e268-78.
6. 6. Ryan NAJ, Evans DG, Green K, Crosbie EJ. Pathological features and clinical behavior of Lynch syndrome-associated ovarian cancer. Gynecol Oncol. 2017;144(3):491-5
7. 7. Stelloo E, Jansen AML, Osse EM, Nout RA, Creutzberg CL, Ruano D, et al. Practical guidance for mismatch repair-deficiency testing in endometrial cancer. Ann Oncol. 2017;28(1):96-102.
8. 8. Le DT, Durham JN, Smith KN, Wang H, Bartlett BR, Aulakh LK, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017;357(6349):409-13.

9. 9. Gupta P, Kapatia G, Gupta N, Ballari N, Rai B, Suri V, et al. Mismatch Repair Deficiency in Adult Granulosa Cell Tumors: an Immunohistochemistry-based Preliminary Study. Appl Immunohistochem Mol Morphol. 2022;30(8):540-8.